医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

sTLR4/MD-2 complex inhibits colorectal cancer migration and invasiveness in vitro and in vivo by IncRNA H19 down-regulation

摘要Long non-coding RNAs (IncRNAs) have multiple functions in gene regulation and during cellular processes.However,the functional roles of IncRNAs in colorectal cancer (CRC) have not yet been well understood.In our previous study,we demonstrated that sTLR4/MD-2 complex can inhibit CRC in vitro and in vivo by targeting LPS.Therefore,the aim of the present study is to investigate the expression of IncRNA H19 in CRC and to evaluate its effect on the inhibition of sTLR4/MD-2 complex.The expression of H19 is measured in 63 CRC tumor tissues and adjacent normal tissues by quantitative real-time PCR (qRT-PCR).The effects of H19 on migration and invasiveness are evaluated by wound healing assay,migration and invasion assays.Results showed that H19 is significantly overexpressed in cancerous tissues and CRC cell lines compared with adjacent normal tissues and a normal human intestinal epithelial cell line.Moreover,H19 overexpression is closely associated with CRC patients.Our in vitro data indicated that knockdown of H19 inhibits the migration and invasiveness of CRC cells.And in vivo sTLR4/MD-2 complex inhibits tumor growth in mice and the expression of H19 is down-regulated.These results suggest that sTLR4/MD-2 complex inhibits CRC migration and invasiveness in vitro and in vivo by IncRNA H19 down-regulation.

更多
广告
提交
  • 浏览1
  • 下载0
生物化学与生物物理学报(英文版)

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷